...究 抗药性 抗氯喹 第1例 【文 摘】自从1959年第1例抗氯喹的恶性疟病人出现以来,恶性疟原虫氯喹抗药性(chloroquine resistance,CQR)已经遍及所有恶性疟流行地区,在东南亚地区CQR引发了更为严重的公共卫生问题,在我国云南、海南等省也有...
基于8个网页-相关网页
...抗药性 抗氯喹 第1例 【文 摘】自从1959年第1例抗氯喹的恶性疟病人出现以来,恶性疟原虫氯喹抗药性(chloroquine resistance,CQR)已经遍及所有恶性疟流行地区,在东南亚地区CQR引发了更为严重的公共卫生问题,在我国云南、海南等省也有...
基于2个网页-相关网页
恶性疟原虫氯喹抗药性 chloroquine resistance ; CQR
虽然取得了一定的成效,但疟疾在很多地方又卷土重来,部分原因就是出现了具有抗药性的疟原虫,比如抵抗传统疟疾治疗药物氯喹的疟原虫。
After limited success, the disease rebounded in many places, due in part to the emergence of parasites that resisted drugs such as chloroquine that had previously held the malady at bay.
直到最近,官方才采用了sulfadoxine - pyrimethamine (SP)的治疗方法,但氯喹的使用范围仍很广,尽管它有着很强的抗药性。
Until recently, the official treatment policy for malaria was sulfadoxine-pyrimethamine (sp). Chloroquine, however, is still widely used despite significant drug resistance.
随着对像氯喹这样在亚洲、非洲和南美洲广泛应用并曾经有效的抗疟疾药的抗药性的出现,疟疾的治疗状况可能更令人堪忧,“我们已处在绝望的境地。”
With resistance to once effective antimalarials like chloroquine now widespread in Asia, Africa and South America , the prognosis could not seem more grim. "We're in a desperate situation."
应用推荐